Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Harvey

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Nature Aging|April 28, 2023
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homesGokhan Tut, Tara Lancaster, Maria Krutikov, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United StatesAmanda C Perofsky, John Huddleston, Chelsea Hansen, et al.
Nature Microbiology|August 14, 2019
The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strainHongquan Wan, Jin Gao, Hua Yang, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 19, 2024
A case of swine influenza A(H1N2)v in England, November 2023Jade Cogdale, Beatrix Kele, Richard Myers, et al.
Elife|September 25, 2024
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United StatesAmanda C Perofsky, John Huddleston, Chelsea L Hansen, et al.
Plos Pathogens|February 26, 2021
Breadth and function of antibody response to acute SARS-CoV-2 infection in humansKuan-Ying A Huang, Tiong Kit Tan, Ting-Hua Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026
Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agentsMerijn B L Vriends, Elisha Moran, Martín Calvelo, et al.
Ebiomedicine|June 11, 2026
Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergenceRuth Harvey, Ceilidh Welsh, Alexander Mp Byrne, et al.
Elife|July 29, 2021
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strainsNikhil Faulkner, Kevin W Ng, Mary Y Wu, et al.
Plos Biology|January 21, 2025
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasionHarriet V Mears, George R Young, Theo Sanderson, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Nature Aging|April 28, 2023
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homesGokhan Tut, Tara Lancaster, Maria Krutikov, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United StatesAmanda C Perofsky, John Huddleston, Chelsea Hansen, et al.
Nature Microbiology|August 14, 2019
The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strainHongquan Wan, Jin Gao, Hua Yang, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 19, 2024
A case of swine influenza A(H1N2)v in England, November 2023Jade Cogdale, Beatrix Kele, Richard Myers, et al.
Elife|September 25, 2024
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United StatesAmanda C Perofsky, John Huddleston, Chelsea L Hansen, et al.
Plos Pathogens|February 26, 2021
Breadth and function of antibody response to acute SARS-CoV-2 infection in humansKuan-Ying A Huang, Tiong Kit Tan, Ting-Hua Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026
Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agentsMerijn B L Vriends, Elisha Moran, Martín Calvelo, et al.
Ebiomedicine|June 11, 2026
Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergenceRuth Harvey, Ceilidh Welsh, Alexander Mp Byrne, et al.
Elife|July 29, 2021
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strainsNikhil Faulkner, Kevin W Ng, Mary Y Wu, et al.
Plos Biology|January 21, 2025
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasionHarriet V Mears, George R Young, Theo Sanderson, et al.
Pageof 7